(Alliance News) - The following is a round-up of London-listed company director and manager changes announced on Monday and not separately reported by Alliance News:
SSE PLC - energy firm - Non-Executive Director Crawford Gilles to step down with effect on Wednesday after five years in the role since 2015. SSE's board to compromise of chair, three executive directors and seven non-executive directors.
Tracsis PLC - traffic data & transportation services - Appoints Andrew Kelly as chief financial officer with effect on February 1, 2021. Will replace Max Cawthra, who is stepping down from role after 10 years since 2011. Kelly is currently vice president of Finance & IT at Vitec Production Solutions, a division of photography & video products maker Vitec Group PLC.
Bank of Cyprus Holdings PLC - banking - First Deputy Chief Executive Officer Chris Patsalides to step down with effect on October 31, after a 25-year tenure with the group. In addition, has appointed Constantine Iordanou as non-executive director and Executive Director of Finance Eliza Livadiotou to board as executive member. Both appointments require approval from European Central Bank.
ULS Technology PLC - Oxfordshire-based conveyancing software provider - Chief Executive Officer Steve Goodall has stepped down from role with immediate effect to pursue other interests, after three years since 2017. Following an extensive search, the group has found a successor with extensive performance, but has not disclosed who the successor is.
Henderson European Focus Trust PLC - investment trust - Appoints Senior Independent Director Vicky Hastings as interim chair, following the stepping down of Chair Robert Jeens with effect on Friday last week, for personal reasons, after ten months in the role since December 2019.
Ovoca Bio PLC - Women's health-focused biopharmaceutical company - Appoints Chief Executive Officer Kirill Golovanov as interim chair with immediate effect, following the death of Executive Chair Mikhail Mogutov on Thursday last week, after 12 years in the role.
Vectura Group PLC - London-based drug delivery products firm - Non-Executive Director Anne Whitaker to step down with effect on Wednesday, due to potential conflicts that could arise in the future, from her role as chief executive officer at Aerami Therapeutics, which specialises in the treatment of severe respiratory and chronic diseases.
Mereo Biopharma Group PLC - London-based clinical-stage biopharmaceutical company focused on oncology and rare diseases - Appoints Brian Schwartz and Jeremy Bender as non-executive directors with effect on October 1. In addition, Non-Executive Director Paul Blackburn to step down after five years since 2015.
British Smaller Companies VCT2 PLC - UK-focused venture capital trust - Appoints Barbara Anderson with effect on October 1. Also announced the resignation of Robert Pettigrew with effect at the end of 2020 after 20 years in the role.
Blue Prism Group PLC - Warrington, England-based robotic process automation - Appoints Rachel Mooney as non-executive director with immediate effect.
By Dayo Laniyan; email@example.com
Copyright 2020 Alliance News Limited. All Rights Reserved.